| 174.9693 0.519 (0.3%) | 10-16 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 207.22 |
1-year : | 242.03 |
| Resists | First : | 177.41 |
Second : | 207.22 |
| Pivot price | 171.91 |
|||
| Supports | First : | 167.21 |
Second : | 160.91 |
| MAs | MA(5) : | 173.7 |
MA(20) : | 170.28 |
| MA(100) : | 161.74 |
MA(250) : | 160.6  |
|
| MACD | MACD : | 2.3 |
Signal : | 2.1 |
| %K %D | K(14,3) : | 84.7 |
D(3) : | 82.3 |
| RSI | RSI(14): 63 |
|||
| 52-week | High : | 178.66 | Low : | 135.33 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ BBH ] has closed below upper band by 32.2%. Bollinger Bands are 64.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 9 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 177.44 - 178.05 | 178.05 - 178.62 |
| Low: | 172.54 - 173.35 | 173.35 - 174.08 |
| Close: | 173.71 - 174.82 | 174.82 - 175.83 |
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Wed, 08 Oct 2025
VanEck Biotech ETF (BBH): How to Buy - The Motley Fool
Thu, 02 Oct 2025
The Best Biotech ETFs to Buy - Kiplinger
Mon, 01 Sep 2025
BBH Vs. IBB: How To Prepare For The Next Biotech Growth Cycle With BBH (NASDAQ:IBB) - Seeking Alpha
Mon, 01 Sep 2025
Should You Invest in the VanEck Biotech ETF (BBH)? - Yahoo Finance
Wed, 13 Aug 2025
7 Best Biotech ETFs to Buy Now | Investing - Money US News.com
Mon, 30 Jun 2025
Should You Invest in the VanEck Biotech ETF (BBH)? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|